Literature DB >> 20332730

Functional living skills assessment: a standardized measure of high-order activities of daily living in patients with dementia.

E Farina1, R Fioravanti, R Pignatti, M Alberoni, F Mantovani, G Manzoni, L Chiavari, E Imbornone, F Villanelli, R Nemni.   

Abstract

AIM: Performance measures are tools aimed to directly evaluate social function in older adults. The authors present the standardization of a new direct performance measure for patients with dementia, the functional living skills assessment (FLSA).
METHODS: FLSA was conceived to detect functional impairment in very mild to moderate patients and to pick up functional modification due to intervention. The patient is asked to perform an activity, and the performance is scored according to completeness and level of assistance required. Eight areas of interest are evaluated (Resources, Consumer Skills, Public Transportation, Time Management, Money management, Leisure, Telephone Skills, Self-Care and Health). Subjects included 54 patients with dementia and 36 normal controls.
RESULTS: Total and partial FLSA scores significantly differed for the two groups (P<0.0001). Performance on FLSA could divide clinical dementia rating (CDR) 0 from CDR 1, CDR 2 e CDR 3 groups. Both sensitivity and specificity were 94%; inter-rater and test-retest reliability was good (P>0.9). Correction scores for education were calculated, while age influence was only marginally significant. Mini Mental State Examination (MMSE) and CDR highly influenced FLSA score (P< 0.0001); FLSA was highly correlated with another performance measure (the Direct Assessment of Functional Status; P=0.821), and with the Instrumental Activity of Daily Living (IADL) scale (P=-0.612), while no significant correlation was present with the Geriatric Depression Scale.
CONCLUSION: FLSA evidences construct, concurrent and discriminative validity. We suggest that this tool could be possibly useful when a high sensibility to different levels of functional impairment is needed, as evaluation of treatment efficacy (both non-pharmacological and pharmacological) identification of relatively intact functional areas to plan cognitive rehabilitation, and confirmation of dementia in the initial phase when there are doubts about functional decline.

Entities:  

Mesh:

Year:  2010        PMID: 20332730

Source DB:  PubMed          Journal:  Eur J Phys Rehabil Med        ISSN: 1973-9087            Impact factor:   2.874


  8 in total

1.  Clinical Utility of Select Neuropsychological Assessment Battery Tests in Predicting Functional Abilities in Dementia.

Authors:  Lee Ashendorf; Michael L Alosco; Hanaan Bing-Canar; Kimberly R Chapman; Brett Martin; Christine E Chaisson; Diane Dixon; Eric G Steinberg; Yorghos Tripodis; Neil W Kowall; Robert A Stern
Journal:  Arch Clin Neuropsychol       Date:  2018-08-01       Impact factor: 2.813

2.  Ecological Assessment of Autonomy in Instrumental Activities of Daily Living in Dementia Patients by the Means of an Automatic Video Monitoring System.

Authors:  Alexandra König; Carlos Fernando Crispim-Junior; Alvaro Gomez Uria Covella; Francois Bremond; Alexandre Derreumaux; Gregory Bensadoun; Renaud David; Frans Verhey; Pauline Aalten; Philippe Robert
Journal:  Front Aging Neurosci       Date:  2015-06-02       Impact factor: 5.750

3.  A Direct Performance Test for Assessing Activities of Daily Living in Patients with Mild Degenerative Dementia: The Development of the ETAM and Preliminary Results.

Authors:  Anke Schmiedeberg-Sohn; Elmar Graessel; Katharina Luttenberger
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-03-04

4.  The Erlangen test of activities of daily living in persons with mild dementia or mild cognitive impairment (ETAM) - an extended validation.

Authors:  Stephanie Book; Katharina Luttenberger; Mark Stemmler; Sebastian Meyer; Elmar Graessel
Journal:  BMC Psychiatry       Date:  2018-09-24       Impact factor: 3.630

5.  A French-Greek Cross-Site Comparison Study of the Use of Automatic Video Analyses for the Assessment of Autonomy in Dementia Patients.

Authors:  Anastasios Karakostas; Alexandra König; Carlos Fernando Crispim-Junior; François Bremond; Alexandre Derreumaux; Ioulietta Lazarou; Ioannis Kompatsiaris; Magda Tsolaki; Philippe Robert
Journal:  Biosensors (Basel)       Date:  2020-08-21

6.  Validation of the Erlangen Test of Activities of Daily Living in Persons with Mild Dementia or Mild Cognitive Impairment (ETAM).

Authors:  Katharina Luttenberger; Simone Reppermund; Anke Schmiedeberg-Sohn; Stephanie Book; Elmar Graessel
Journal:  BMC Geriatr       Date:  2016-05-26       Impact factor: 3.921

7.  Chronic stepwise cerebral hypoperfusion differentially induces synaptic proteome changes in the frontal cortex, occipital cortex, and hippocampus in rats.

Authors:  Vanda Tukacs; Dániel Mittli; Balázs András Györffy; Éva Hunyady-Gulyás; Dávid Hlatky; Vilmos Tóth; Lilla Ravasz; F Katalin Medzihradszky; Gabriella Nyitrai; András Czurkó; Gábor Juhász; József Kardos; Katalin Adrienna Kékesi
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

Review 8.  Exploring outcome measures with cognitive stimulation therapies and how these relate to the experiences of people with dementia: A narrative literature review.

Authors:  Alison R Ward; Diana Schack Thoft; Ann Lykkegaard Sørensen
Journal:  Dementia (London)       Date:  2022-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.